See more : Epiphany Technology Acquisition Corp. (EPHYU) Income Statement Analysis – Financial Results
Complete financial analysis of OnKure Therapeutics, Inc. (OKUR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of OnKure Therapeutics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Zhejiang Yayi Metal Technology Co.,Ltd (301113.SZ) Income Statement Analysis – Financial Results
- Chatham Lodging Trust (CLDT-PA) Income Statement Analysis – Financial Results
- Paragon ID SA (PID.PA) Income Statement Analysis – Financial Results
- Premier Products Public Company Limited (PPP.BK) Income Statement Analysis – Financial Results
- Icade SA (ICAD.PA) Income Statement Analysis – Financial Results
OnKure Therapeutics, Inc. (OKUR)
About OnKure Therapeutics, Inc.
OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.
OnKure Announces New Date for Upcoming Investor Call
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
Source: https://incomestatements.info
Category: Stock Reports